In brief

AstraZeneca rejects Pfizer’s final takeover bid: The board of the UK drug company AstraZeneca has turned down what the US drug company Pfizer has said was its final takeover bid of £69bn (€85bn; $120m), saying that the bid “undervalues” the UK company and its “attractive prospects.” Leif Johansson, AstraZeneca’s chairman, said that Pfizer’s approach was driven by corporate financial benefits and tax minimisation rather than a “strategic, business, or value case.” MPs have raised concerns that the takeover would have …